Lipase Market is expected to Hit US$ 1.23 billion by 2033 | Major Companies - Renco New Zealand, Amano Enzymes Inc., Advanced Enzyme Tech, Clerici-Sacco Group

DataM Intelligence has unveiled its latest report on the "Lipase Market Size 2026" delivering powerful insights into key trends, future growth opportunities, and evolving market challenges. Designed to empower smarter decision-making, the report equips businesses with the strategic intelligence needed to stay ahead in a competitive landscape. By blending robust qualitative analysis with data-driven quantitative research, DataM Intelligence offers a well-rounded perspective that helps organizations decode complex market dynamics, unlock new avenues for growth, and seize emerging opportunities in an ever-evolving global market.

Unlock Strategic Partnerships in the Growing Lipase Market-Connect with Key Industry Leaders Today: https://www.datamintelligence.com/partner-identification-enquiry/lipase-market?sz

The Global Lipase Market size reached US$ 0.80 billion in 2025 and is expected to reach US$ 1.23 billion by 2033, growing with a CAGR of 5.8% during the forecast period 2026-2033.

The Lipase Market refers to the global industry involved in the production, distribution, and application of lipase enzymes, which catalyze the breakdown of fats into fatty acids and glycerol. Lipases are widely used across food and beverage processing, detergents, pharmaceuticals, animal feed, biofuels, and biotechnology industries due to their efficiency, specificity, and eco-friendly properties. Market growth is driven by increasing demand for enzyme-based solutions, advancements in industrial biotechnology, expanding applications in healthcare and nutrition, and the rising focus on sustainable manufacturing processes worldwide.

Download Free Sample Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/lipase-market?sz

Recent Industry Developments: United States

✅ April 2026: BioMarin completed the acquisition of Amicus Therapeutics, strengthening its lysosomal storage disease portfolio, including Pompe disease therapies that rely on enzyme replacement technologies, supporting broader growth in the enzyme therapeutics segment.

✅ April 2026: Chiesi Group announced the acquisition of KalVista Pharmaceuticals for approximately US$1.9 billion, expanding its rare disease portfolio and reinforcing investment in advanced enzyme-related therapeutic areas within the U.S. biopharmaceutical market.

✅ March 2026: Shionogi enrolled the first patients in its global Phase II trial for S-606001 targeting late-onset Pompe disease in the United States, highlighting continued innovation in enzyme-based treatment development.

Recent Industry Developments: Japan

✅ March 2026: Shionogi initiated a global Phase II clinical study of S-606001 for late-onset Pompe disease, reflecting Japan's ongoing investment in enzyme-related therapies and metabolic disorder treatment research.

✅ March 2026: Cowellnex and Metagen launched joint research utilizing high-precision gut microbiota data to develop new health-testing services, supporting growth in Japan's biotechnology and enzyme-driven health solutions sector.

✅ January 2026: Takeda entered a global collaboration and licensing agreement with Halozyme Therapeutics for ENHANZE® drug-delivery technology, strengthening Japan's biopharmaceutical innovation ecosystem and advanced enzyme-enabled therapeutic development.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/lipase-market?sz

List of the Key Players in the Lipase Market:

Koninklijke DSM N.V
Novozymes A/S
Clerici-Sacco Group
Renco New Zealand
Enzyme Development Corporation
Chr. Hansen Holdings A/S
Amano Enzymes Inc.
Associated British Foods PLC
International Flavors & Fragrances Inc.
Advanced Enzyme Tech

How Does Market Research Work in the Lipase Market?

Market research for the Lipase Market involves systematic data collection and analysis to understand industry trends, customer behavior, and competitive dynamics. It includes primary research such as surveys and interviews, and secondary research from reports, databases, and publications. Analysts evaluate market size, growth drivers, challenges, and opportunities using qualitative and quantitative methods. Insights are validated through expert opinions and forecasting models, enabling businesses to make strategic decisions, identify target segments, and gain a competitive advantage in a rapidly evolving market.

Latest Mergers and Acquisitions of Lipase Market:

✅ May 2026: Gyre Therapeutics Completes Acquisition of Cullgen
➠ Gyre Therapeutics completed its acquisition of Cullgen, creating a fully integrated U.S.- and China-based biopharmaceutical organization. The transaction enhances Gyre's biotechnology platform and strengthens its research capabilities in enzyme-linked and metabolic disease therapies.

✅ May 2026: Angelini Pharma Acquires Catalyst Pharmaceuticals
➠ Angelini Pharma agreed to acquire Catalyst Pharmaceuticals for approximately US$4.1 billion. The acquisition expands Angelini Pharma's rare disease portfolio and supports its strategic growth in specialty therapeutics, including enzyme-based treatment segments.

✅ April 2026: Chiesi Group Acquires KalVista Pharmaceuticals
➠ Chiesi Group entered into a definitive agreement to acquire KalVista Pharmaceuticals for approximately US$1.9 billion. The acquisition strengthens Chiesi's rare disease portfolio and expands its enzyme-related therapeutic capabilities through advanced treatments for hereditary angioedema.

Segments Covered in the Lipase Market 2026:

By Source: Microbial, Animal, Plant.

By Form: Liquid, Powder.

By Application: Dairy, Bakery and Confectionery, Animal Feed, Others.

Regional Analysis of the Lipase Market:

⇥ North America: Leads the market due to advanced infrastructure, strong R&D investments, and early adoption of new technologies.

⇥ Europe: Shows steady growth supported by strict regulations and increasing focus on sustainability initiatives.

⇥ Asia-Pacific: Fastest-growing region driven by rapid industrialization, urbanization, and rising consumer demand in emerging economies.

⇥ Latin America: Experiences moderate growth with expansion in industrial and commercial sectors.

⇥ Middle East & Africa: Gradual market growth supported by increasing investments and improving economic conditions.

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=lipase-market

Key Benefits of the Report:

⏩ Comprehensive Market Insights: Gain a deep understanding of market size, trends, and structure.

⏩ Accurate Forecasting: Access reliable future projections to support long-term planning.

⏩ Competitive Analysis: Identify key players, strategies, and positioning in the market.

⏩ Data-Driven Decisions: Make informed business choices backed by verified data.

⏩ Opportunity Identification: Discover emerging trends and untapped growth areas.

⏩ Risk Mitigation: Reduce uncertainties with thorough market evaluation.

⏩ Customer Insights: Understand consumer behavior, preferences, and buying patterns.

⏩ Strategic Planning Support: Align business strategies with market realities.

⏩ Time & Cost Efficiency: Save resources by leveraging ready-to-use research.

⏩ Customization & Expert Validation: Benefit from tailored insights and industry expert analysis.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Lipase Market in 2025?
◆ What is the projected growth rate of the Lipase Market through 2033?
◆ Who are the key players in the Lipase Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Fabian
Email: fabian@datamintelligence.com
Phone USA: +1 877-441-4866
Phone UK: +44 161-870-5507
Website:https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.